Alyeska Investment Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-451,146
| Closed | -$37.7M | – | 694 |
|
2024
Q4 | $37.7M | Sell |
451,146
-479,984
| -52% | -$40.1M | 0.14% | 177 |
|
2024
Q3 | $68.1M | Sell |
931,130
-463,402
| -33% | -$33.9M | 0.35% | 100 |
|
2024
Q2 | $95.5M | Buy |
1,394,532
+1,142,612
| +454% | +$78.3M | 0.55% | 46 |
|
2024
Q1 | $17.4M | Buy |
251,920
+133,137
| +112% | +$9.21M | 0.11% | 219 |
|
2023
Q4 | $8.51M | Sell |
118,783
-12,917
| -10% | -$925K | 0.06% | 270 |
|
2023
Q3 | $6.86M | Buy |
131,700
+93,700
| +247% | +$4.88M | 0.05% | 315 |
|
2023
Q2 | $2.41M | Sell |
38,000
-12,000
| -24% | -$760K | 0.02% | 376 |
|
2023
Q1 | $2.71M | Buy |
+50,000
| New | +$2.71M | 0.02% | 325 |
|
2021
Q1 | – | Sell |
-218,473
| Closed | -$6.95M | – | 833 |
|
2020
Q4 | $6.95M | Sell |
218,473
-337,839
| -61% | -$10.7M | 0.1% | 230 |
|
2020
Q3 | $14.3M | Buy |
556,312
+287,912
| +107% | +$7.39M | 0.22% | 147 |
|
2020
Q2 | $6.89M | Sell |
268,400
-209,026
| -44% | -$5.37M | 0.1% | 231 |
|
2020
Q1 | $7.34M | Buy |
+477,426
| New | +$7.34M | 0.15% | 156 |
|
2017
Q4 | – | Sell |
-548,955
| Closed | -$8.66M | – | 512 |
|
2017
Q3 | $8.66M | Buy |
+548,955
| New | +$8.66M | 0.06% | 240 |
|
2015
Q4 | – | Sell |
-50,000
| Closed | -$2M | – | 463 |
|
2015
Q3 | $2M | Buy |
50,000
+37,485
| +300% | +$1.5M | 0.02% | 325 |
|
2015
Q2 | $400K | Sell |
12,515
-6,393
| -34% | -$204K | ﹤0.01% | 439 |
|
2015
Q1 | $452K | Sell |
18,908
-38,945
| -67% | -$931K | 0.01% | 446 |
|
2014
Q4 | $1.02M | Sell |
57,853
-2,142
| -4% | -$37.8K | 0.02% | 380 |
|
2014
Q3 | $823K | Sell |
59,995
-65,498
| -52% | -$898K | 0.02% | 321 |
|
2014
Q2 | $2.12M | Sell |
125,493
-69,070
| -36% | -$1.16M | 0.05% | 277 |
|
2014
Q1 | $3.54M | Buy |
+194,563
| New | +$3.54M | 0.1% | 184 |
|